Response to neoadjuvant chemotherapy in breast cancer: do microRNAs matter?

BACKGROUND: Conventionally, breast cancer (BC) prognosis and prediction of response to therapy are based on TNM staging, histological and molecular subtype, as well as genetic alterations. The role of various epigenetic factors has been elucidated in carcinogenesis. However, it is still unknown to w...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryspayeva, Dinara, Halytskiy, Volodymyr, Kobyliak, Nazarii, Dosenko, Iryna, Fedosov, Artem, Inomistova, Mariia, Drevytska, Tetyana, Gurianov, Vitalyi, Sulaieva, Oksana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170858/
https://www.ncbi.nlm.nih.gov/pubmed/35668332
http://dx.doi.org/10.1007/s12672-022-00507-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170858/
https://www.ncbi.nlm.nih.gov/pubmed/35668332
http://dx.doi.org/10.1007/s12672-022-00507-z

Ejemplares similares